Press release
Global Gastric Cancer Drugs Market Outlook 2025-2034: Trends, Innovations, And Future Outlook
Gastric Cancer Drugs
What Is the Gastric Cancer Drugs Market Size and Projected Growth Rate?
In recent times, the market size for gastric cancer drugs has seen a swift expansion. It is projected to rise from $4.43 billion in 2024 to $5.01 billion in 2025, experiencing a compound annual growth rate (CAGR) of 12.9%. The noticeable growth in the historic period is due to various factors such as a surge in R&D spending in the pharmaceutical sector, growth in healthcare expenditure, robust economic development in emerging markets, and a significant increase in the elderly population.
In the upcoming years, the market for gastric cancer drugs is predicted to experience a significant expansion. Its value is projected to reach $7.6 billion in 2029, with a compound annual growth rate (CAGR) of 11.0%. The growth anticipated in this period is largely due to factors such as an increasing incidence of gastric cancer, a robust pipeline of drugs, ascending healthcare spend, the rise in elderly population, and tweaked FDA guidelines promoting the development of biologics drugs. The impending forecast period will see a surge in strategic collaborations and pacts to widen product offerings, cooperation with other business entities or government agencies, augmented number of studies undertaken to formulate new gastric cancer drugs, investment in artificial intelligence to lower R&D expenses, and the proliferation of next-gen biologics alongside the application of CRISPR-Cas9 technology in the creation of new medications.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2603
What Are the Major Segments in the Gastric Cancer Drugs Market?
The gastric cancer drugs market covered in this report is segmented -
1) By Type: Imatinib, Trastuzumab, Other Types
2) By Route of Administration: Oral, Parenteral
3) By End User: Hospitals, Clinics, Cancer Speciality Centers
Subsegments:
1) By Imatinib: Oral Formulations, Injectable Formulations, Combination Therapies
2) By Trastuzumab: Monotherapy, Combination Therapy With Chemotherapy, Biosimilars Of Trastuzumab
3) By Other Types: Chemotherapy Agents, Targeted Therapy Agents, Immunotherapy Agents, Supportive Care Medications
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2603&type=smp
What Are The Driving Gastric Cancer Drugs Market Evolution?
The rising counts of obese individuals coupled with the growing smoking populace has led to a surge in gastric cancer cases. Risk factors for stomach cancer are magnified with the intake of tobacco and maintaining an unhealthy diet. For example, data reported by the Government Digital Service, a government agency in the UK, stated that obesity rates in England for 2022-2023 stood at 25.9% for adults (18 years and older), marking an increase from the previous year's 25.2%. This uptick in gastric cancer instances will propel the expansion of the gastric cancer drugs market.
Which Firms Dominate The Gastric Cancer Drugs Market Segments?
Major companies operating in the gastric cancer drugs market include F. Hoffmann-La Roche, Eli Lilly and Company, Otsuka Pharmaceutical, Jiangsu HengRui Medicine, Biocon, Sanofi, PV Pharma Healthcare (India), Roche India, Novartis Oncology, Arlak Biotech (India), Healthkind labs Pvt. Ltd., SwisscheM Healthcare Pvt.Ltd, Apikos Pharma, Kolaz biotech., CStone Pharma (China), CARsgen Therapeutics (China), JW Therapeutics (China), BeiGene(China), Takeda Pharmaceuticals (Japan), Astellas Pharma Inc (Japan), Daiichi Pharmaceutical and Sankyo (Japan), AQVIDA GmbH, AstraZeneca plc, GlaxoSmithKline plc, Veropharm, Biocad, Bristol-Myers Squibb, Celon Pharma, Celltrion Inc., Imugene Limited, Merck & Co. Inc., Pfizer Inc., Sandoz AG (A Novartis Division), Eurofarma Laboratórios S.A., TUTEUR ArgentinaPierre Fabre Group, Celnova Pharma, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO), Gulf Pharmaceutical Industries (Julphar), Abbott Laboratories, Mylan Laboratories, Gilead Sciences, BMS, Ascedis Health
What Trends Are Expected to Dominate the Gastric Cancer Drugs Market in the Next 5 Years?
Numerous enterprises in the gastric cancer drugs market are developing cutting-edge products such as anti-PD-1 therapies to promote the effectiveness of treatments and enhance patient outcomes. Anti-PD-1 therapy is an immunotherapy that targets the programmed cell death protein 1 (PD-1) receptor found on immune cells. For instance, in November 2023, Merck & Co., Inc., a pharmaceutical firm based in the United States secured approval from the Food and Drug Administration (FDA), a US federal agency responsible for public health protection, for KEYTRUDA (pembrolizumab). This drug, KEYTRUDA (pembrolizumab), is an anti-PD-1 therapy applied in treating gastric cancer. It's particularly for the first-line treatment of patients suffering from locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma. The drug is recommended for use alongside trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy. The approval was given hastily due to the observed tumor response rate and the response's longevity.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report
Which Is The Largest Region In The Gastric Cancer Drugs Market?
North America was the largest region in the gastric cancer drugs market in 2024. Middle East is expected to be the largest growing region in the global gastric cancer drugs market share during the forecast period. The regions covered in the gastric cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Gastric Cancer Drugs Market?
2. What is the CAGR expected in the Gastric Cancer Drugs Market?
3. What Are the Key Innovations Transforming the Gastric Cancer Drugs Industry?
4. Which Region Is Leading the Gastric Cancer Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Gastric Cancer Drugs Market Outlook 2025-2034: Trends, Innovations, And Future Outlook here
News-ID: 4004591 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
